Slides and webcasts from all ESMO Preceptorship courses are open to all with at least a free ESMO account, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.
ESMO - The Christie Preceptorship on Lung Cancer 2023: Manchester
- Start date
- 01 Mar 2023
- End date
- 03 Mar 2023
- Location
- Manchester, United Kingdom
Learning objectives
- To learn about the evidence-base for lung cancer screening and novel diagnostic modalities
- To learn about the management of early stage NSCLC and use of adjuvant treatments
- To understand the role of multi-modality treatment in locally advanced NSCLC and limited stage SCLC
- To learn about the management of patients with actionable driver mutations and novel targeted agents for advanced NSCLC
- To understand the role of immune-checkpoint blockade for lung cancer and to learn about novel immunotherapies
- To learn about treatment of NSCLC with oligometastatic disease
- To learn about the systemic treatment of mesothelioma and SCLC
- To learn about the role of supportive and palliative care for thoracic malignancies
Download the preliminary programme
How to apply
Application is via online form. During the application process you will be required to upload the following:
- Your CV including a list of your publications
- 3-5 slides presenting a clinical case (please use the ESMO Preceptorship Case Presentation Power Point template, provided here)
Application deadline
Application for the course are now closed.
Who can apply?
While this course is primarily aimed at oncologists resident in Europe, application is open to all ESMO members.
To apply, ESMO membership is mandatory. If you are not an ESMO member or need to renew your membership, please visit the ESMO membership pages.
ESMO COVID-19 Regulations
Each participant needs to check and comply with the latest health and travel regulations to ensure a fast and easy journey.
ESMO requires that all attendees are fully vaccinated against Covid-19 OR recovered in the last 6 months with at least one dose of a vaccine by the time of the meeting. Vaccination proof will not be checked by ESMO.
Additionally, we strongly recommend:
- Testing for Covid-19 within 48 hours prior to the inbound trip with a molecular, rapid antigen or self-test. The result will not be checked by ESMO
- Wearing a face mask in closed spaces
- Avoid shaking hands; wash your hands regularly and use hand sanitizer
The individual safety and hygiene measures of all participants is our priority, so we implemented additional measures on-site at the venue:
- Hand sanitizer and masks will be available
- All surfaces will be disinfected on a regular basis
The Christie’s COVID-19 Regulations
Upon entering The Christie NHS Foundation Trust, clinical face coverings are available and must be worn throughout the main hospital patient/public areas. When reaching the 2nd floor of the Education Centre (Dept. 17) these can then be removed should you wish to do so. Face coverings will need to be worn again when leaving the education centre to exit the hospital building.
Any changes to the COVID-19 Regulations will be communicated on this webpage.
Insurance
ESMO bears no responsibility for any untoward events in connection with, before, during and after the course. Participants are strongly advised to take out their own personal and travel coverage.
What's included?
Successful applicants will benefit from complimentary course registration.
Travel grant
In addition to the course registration, a travel grant of maximum 600 euros is offered to selected applicants as a contribution versus their travel and accommodation costs. The reimbursement will be processed after the course against original invoices/vouchers.
In order to help you in the selection of the most convenient accommodation to reach the Preceptorship venue, we are happy to provide you the with the link to the Accommodation Booking Provider for the ESMO-The Christie Preceptorship on Lung Cancer, available here.
Accreditation
The programme of this event has been accredited with 16 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-Chairs
Fiona Blackhall, United Kingdom
Raffaele Califano, United Kingdom
Pilar Garrido Lopez, Spain
Venue
The Christie School of Oncology
The Christie NHS Foundation Trust
Education Centre (Dept. 17)
Wilmslow Road
Manchester, M20 4BX – United Kingdom
Supported by
